Literature DB >> 28306228

Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome.

Peter H Byers, John Belmont, James Black, Julie De Backer, Michael Frank, Xavier Jeunemaitre, Diana Johnson, Melanie Pepin, Leema Robert, Lynn Sanders, Nigel Wheeldon.   

Abstract

Vascular Ehlers Danlos syndrome (vEDS) is an uncommon genetic disorders characterized by arterial aneurysm, dissection and rupture, bowel rupture, and rupture of the gravid uterus. The frequency is estimated as 1/50,000-1/200,000 and results from pathogenic variants in COL3A1, which encodes the chains of type III procollagen, a major protein in vessel walls and hollow organs. Initial diagnosis depends on the recognitions of clinical features, including family history. Management is complex and requires multiple specialists who can respond to and manage the major complications. A summary of recommendations for management include: Identify causative variants in COL3A1 prior to application of diagnosis, modulate life style to minimize injury, risk of vessel/organ rupture, identify and create care team, provide individual plans for emergency care ("vascular EDS passport") with diagnosis and management plan for use when traveling, centralize management at centers of excellence (experience) when feasible, maintain blood pressure in the normal range and treat hypertension aggressively, surveillance of vascular tree by doppler ultrasound, CTA (low radiation alternatives) or MRA if feasible on an annual basis. These recommendations represent a consensus of an international group of specialists with a broad aggregate experience in the care of individuals with vascular EDS that will need to be assessed on a regular basis as new information develops.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; aterial rupture; vascular EDS

Mesh:

Substances:

Year:  2017        PMID: 28306228     DOI: 10.1002/ajmg.c.31553

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  56 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

2.  A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Dawn M Coleman; Frank M Davis; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Kristofer Charlton-Ouw; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Devin Zarkowsky; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Ellen S Regalado; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-07-26       Impact factor: 4.268

3.  Use of Cluster Analysis to Delineate Symptom Profiles in an Ehlers-Danlos Syndrome Patient Population.

Authors:  Jane R Schubart; Eric Schaefer; Alan J Hakim; Clair A Francomano; Rebecca Bascom
Journal:  J Pain Symptom Manage       Date:  2019-05-31       Impact factor: 3.612

Review 4.  From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta.

Authors:  Jean-Baptiste Michel; Guillaume Jondeau; Dianna M Milewicz
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

5.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

Review 6.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

Review 7.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

Review 8.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

9.  Heritable disorders of connective tissue: Description of a data repository and initial cohort characterization.

Authors:  Rebecca Bascom; Jane R Schubart; Susan Mills; Thomas Smith; Linda M Zukley; Clair A Francomano; Nazli McDonnell
Journal:  Am J Med Genet A       Date:  2019-02-01       Impact factor: 2.802

10.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.